MeRethon RCT : A prospective, open-label, multicentre, randomized, non-inferiority clinical trial to compare the safety and performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System versus Contemporary DES platforms in patients with de novo coronary artery lesions. - MeRes100ââ??¢ Sirolimus-eluting BRS
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2022) vom: 17. Okt. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Indonesisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 13-08-2021, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
CTRI/2021/08/035665 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
WHO007875185 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WHO007875185 | ||
| 003 | DE-627 | ||
| 005 | 20230425182114.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210913s2022 xx |||||o 00| ||ind c | ||
| 035 | |a (DE-627)WHO007875185 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)CTRI/2021/08/035665 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)MLS/MER/MeRethon RCT Version 1.0.0 dated 18-March-2021 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ind | ||
| 245 | 1 | 0 | |a MeRethon RCT |b A prospective, open-label, multicentre, randomized, non-inferiority clinical trial to compare the safety and performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System versus Contemporary DES platforms in patients with de novo coronary artery lesions. - MeRes100ââ??¢ Sirolimus-eluting BRS |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 13-08-2021, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery | |
| 650 | 4 | |a Study Type: PMS | |
| 650 | 4 | |a Phase: Post Marketing Surveillance | |
| 650 | 4 | |a Recruitment Status: Not yet recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2022) vom: 17. Okt. |
| 773 | 1 | 8 | |g year:2022 |g day:17 |g month:10 |
| 856 | 4 | 0 | |u http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55561 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 17 |c 10 | ||